Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer

Table 2 Comparison of short-term and long-term outcomes between emergency surgery and bridge to surgery groups

Characteristic	ES group (n = 90)	BTS group (n = 38)	P-value
Surgical time, (min)	217.89 ± 60.69	204.64 ± 66.13	0.275
Blood loss, (mL)	177.30 ± 134.37	133.68 ± 95.76	0.072
Number of LNs	19.51 ± 9.47	21.45 ± 8.29	0.276
Time to flatus, (d)	3.88 ± 1.65	3.61 ± 1.15	0.359
Time to semi-fluid, (d)	8.62 ± 3.22	8.64 ± 3.96	0.738
Total hospital-stay, (d)	22.17 ± 12.48	22.34 ± 7.78	0.936
Stoma construction, n (%)	20 (22.20)	8 (21.10)	0.884
CD classification system, n (%)			0.547
Grade I	0 (0.00)	2 (2.20)
Grade II	44 (48.90)	16 (42.10)
Grade III	13 (14.40)	5 (13.20)
Grade IV	9 (10.00)	2 (5.30)
Grade V	1 (2.60)	1 (1.10)
Pneumonia, n (%)	18 (20.00)	8 (21.10)	0.892
Incision infection, n (%)	16 (17.80)	5 (13.20)	0.519
ICU intervention, n (%)	8 (8.90)	1 (2.60)	0.192
Leakage, n (%)	3 (3.30)	1 (2.60)	0.658
Sepsis, n (%)	3 (3.30)	1 (2.60)	0.658
SAE, n (%)	23 (25.60)	8 (21.10)	0.587
30 d-mortality, n (%)	1 (1.10)	1 (2.60)	0.507
36-OS time, (mo)	30.10 ± 9.64	29.41 ± 11.33	0.732
36-DFS time, (mo)	27.59 ± 12.19	27.48 ± 12.17	0.969

LN: Lymph node; SEMS: Self-expanding metal stents; BTS: Bridge to surgery; SAE: Severe adverse effects. P < 0.05 was considered statistically significant.